Opening book details…
About this book
Discovery of novel 3-Benzyloxyaminopyridines as orally available and intracranially active selective ROS1 inhibitors for combating the resistant ROS1G2032R mutation by Siming Liu is a book available to read on EtoBox.
- Author
- Siming Liu
- Publisher
- Elsevier Masson SAS
- Published
- 2025
- Language
- EN
More by Siming Liu
Browse all works by Siming Liu
Similar books
- Discovery of Adamantyl Derivatives as Potent and Selective TRPM2 Inhibitors with Significantly Reduced hERG Liability — Tinghao Lu (2025)
- Discovery of Novel 1 H -pyrazolo[3,4- D ]pyrimidine Derivatives as BRK/PTK6 Inhibitors — Baku Acharya (2025)
- A Novel Strategy for Combating Multidrug-resistant Bacteria: Natural Products from Uncultured Microorganisms — Ying-Ying Yang (2025)
- Discovery of Potent and Selective STAT3 Inhibitors Against Triple-negative Breast Cancer — Ru Wang (2025)
- Discovery of Novel Pyrimidine-4,6-diamine-based OLIG2 Inhibitors as Potent Anti-glioblastoma Agents — Zhouyang Xu (2025)
- Discovery of Novel Indazole Derivatives as Type I PRMTs Inhibitors for the Treatment of Triple-negative Breast Cancer — Qiangsheng Zhang (2025)